Prediction accuracy of DXSCNP in BM and PB Validation Analysis subsets defined by AML Type (De Novo vs. Secondary) and availability of samples for both tissue types.
This protocol outlines a real-world observational methodology to systematically evaluate the impact of pre-analytical variables and total laboratory automation (TLA) on the diagnostic performance, eff
Prediction accuracy of DXSCNP in BM and PB Validation Analysis subsets defined by AML Type (De Novo vs. Secondary) and availability of samples for both tissue types.
